C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling

Renal osteodystrophy (ROD) occurs as early as chronic kidney disease (CKD) stage 2 and seems ubiquitous in almost all pediatric patients with CKD stage 5. Fibroblast growth factor (FGF)-23, a bone-derived endocrine regulator of phosphate homeostasis, is overexpressed in CKD and disturbs osteoblast d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dong Dong, Wu, Yang Fang, Chen, Wei Xia, Xu, Yao, Liu, Si Yan, Luo, Huang Huang, Jiang, Guang Mei, Wu, Yue, Hu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802631/
https://www.ncbi.nlm.nih.gov/pubmed/31263178
http://dx.doi.org/10.1038/s12276-019-0265-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802631/
https://www.ncbi.nlm.nih.gov/pubmed/31263178
http://dx.doi.org/10.1038/s12276-019-0265-8

Ejemplares similares